PTX 4.44% 4.7¢ prescient therapeutics limited

Median PFS of 12.2 months for all assessable r/r TCL patients;...

  1. 26 Posts.
    lightbulb Created with Sketch. 28
    Median PFS of 12.2 months for all assessable r/r TCL patients; 13.6 month for r/r CTCL and 7.4 months for r/r PTCL. For context, several key opinion leaders consider a benchmark median PFS for a registration study in r/r TCL is 5-6 months.

    Great announcement regardless of where the share price lands today, setting up for a optimistic and eventful 2024.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
0.002(4.44%)
Mkt cap ! $37.85M
Open High Low Value Volume
4.7¢ 4.7¢ 4.7¢ $13.29K 283.0K

Buyers (Bids)

No. Vol. Price($)
1 2398 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 47429 2
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.